← Back to all trials
Not Yet Recruiting
NCT07854626
Venipuncture Via Nurse-AI Collaboration
Conditions: Peripheral Venous Cannulation for Contrast-enhanced CT/MRI Examination, Peripheral Venous Access Establishment
Sex: All
Healthy volunteers: No
Phase: NA
Enrollment: 3500
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Location: Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou Guangdong
Summary
The goal of this clinical trial is to learn if AI-assisted site selection plus human-machine coordinated puncture improves the quality and safety of peripheral venous access for contrast-enhanced imaging in patients of all ages needing CT/MR contrast scans across three hospitals. The main questions it aims to answer are:
Does the AI-assisted workflow improve the composite success rate of venous cannulation compared with routine nursing? Does this human-machine model raise first-attempt puncture success, shorten procedure time and reduce complications? Researchers will compare the AI-assisted intervention group to the routine nursing control group to see if the AI-assisted human-machine coordinated puncture brings clinical benefits.
Participants will:
* Receive peripheral venous cannulation for contrast-enhanced imaging.
* Have arm images and clinical data collected before and after puncture.
* Complete standardized venous access assessment and 24-hour post-procedure safety observation.
Eligibility Criteria
Inclusion Criteria:
* Patients of all ages scheduled for contrast-enhanced CT/MR examination at three participating centers, who require peripheral venous access.
* Recent renal function test showing estimated glomerular filtration rate (eGFR) \> 30 ml/min/1.73 m².
* Written informed consent obtained from the patient or legal representative, agreeing to radiology specialized nursing service.
Exclusion Criteria:
* Patients with irreversible brain injury or brain death.
* Contraindications to peripheral venipuncture, including history of bilateral mastectomy, extremity venous thrombosis, etc.
* eGFR ≤ 30 ml/min/1.73 m².
* Uncontrolled hyperthyroidism.
* Patients planned for Iodine-131 therapy within the next two weeks.
* Extremely poor vascular conditions that make indwelling needle cannulation impossible.
* Patients receiving contrast-enhanced imaging of both upper limbs.
* Known contraindications to contrast media.
Source: ClinicalTrials.gov (NCT07854626). StuddyBuddy aggregates publicly available trial information.